Transplant Diagnostic Market To Grow Due To The Increasing Demand For Organ Transplantation Till 2024:Grand View Research,inc.
The global transplant diagnostic market is expected to reach
USD 895.2 million by 2024, according to a new report by Grand View Research
Inc. The rising demand for organ transplantation is primarily fueling the
demand for transplant diagnostics.
Constant healthcare research and
development efforts are resulting in the introduction of technically advanced
treatments, such as stem cell therapy and organ transplants. As a result, the
adoption of these highly-advanced organ transplantation techniques is creating
the demand for transplant diagnostics as they reduce the risk of infections and
minimize the chances of an immune response through pre-operative assessments
including histocompatibility tests, such as Human Leukocyte Antigen (HLA)
typing, which determines donor-receiver organ or tissue compatibility prior to
organ transplants.
In addition, pertinent
organizations are supporting research and development initiatives in the field
of organ transplant through grants and funding. As a result, innovative and
advanced diagnostic tools are frequently entering into the market. On the other
hand, high cost of the diagnostic tests is one of the major factors hindering
the growth of the market.
Geographically, the market has
been segmented into North America, Europe, Asia Pacific, Latin America, and
Middle East and Africa (MEA). North America and Europe together accounted for
the largest market share in 2015. Developed economies and well-established
healthcare infrastructure coupled with the presence of a highly developed
research infrastructure are accelerating the adoption of organ and tissue
transplant therapies in Europe and North America. As a consequence, the demand
for transplant diagnostics is high in North America and Europe.
Wide adoption of HLA typing owing
to its ability to determine organ compatibility between the donor and the
receiver preceding organ transplants and to predict potential perioperative
immunological complications is driving the growth of the molecular assay market
in North America and Europe.
Asia Pacific is expected to show
the fastest growth rate during the forecast period owing to the booming medical
tourism in countries, such as India. Availability of advanced healthcare
infrastructure and skilled professionals at a lower cost are anticipated to
attract patients worldwide to this region for transplant procedures.
In addition, the presence of
highly advanced healthcare infrastructure and the ongoing government
initiatives to improve healthcare facilities in the country are collectively
anticipated to boost the market growth in Japan during the forecast period. As
a result, the Asia Pacific market is anticipated to reach USD 216.6 million in
2024.
Browse full research report on Transplant Diagnostic
Market: http://www.grandviewresearch.com/industry-analysis/transplant-diagnostic-market
Further key findings from
the study suggest:
- The PCR-based molecular assay captured the largest
share of the overall market in 2015. The large market share was mainly
attributed to the extensive adoption of the PCR technique in HLA
typing.
- The sequencing-based typing segment is anticipated to
witness significant growth rate from 2016 to 2024. The escalation in the
adoption of next generation sequencing (NGS) is the major factor expected
to drive the growth of this segment during the forecast period.
- The integration of sequencing with serological typing
enhances diagnostic outcomes and, hence is expected to augment the growth
of the sequencing segment during the forecast period
- The reagents and consumables segment accounted for
the largest market share in 2015. This large share is mainly attributed to
the repeat purchase of these products.
- North America captured the largest market share of
around 38% in 2015 and is expected to maintain its dominance throughout the
forecast period. Well-established research infrastructure, the increasing
healthcare expenditure, high adoption rate of the advanced diagnostic
techniques, and the growing R&D activities are some of the factors
supporting the growth of the market in the region.
- Asia Pacific is expected to witness significant
growth during the forecast period owing to the expanding research
opportunities, the increasing health care expenditure, and the rising
awareness of organ donation in the region.
- The booming medical tourism industry offers further
growth opportunities for the market in Asia Pacific
- Some major players in this market include Thermo
Fisher Scientific, Inc., Illumina, Inc., F.Hoffmann La-Roche AG. Abbott
Laboratories, Inc. Qiagen N.V., Immucor Transplant Diagnostics, Inc.,
Bio-Rad Laboratories, Inc., Affymetrix, Inc., and Omixon Ltd.
Browse more reports of this category by Grand View
Research : http://www.grandviewresearch.com/industry/healthcare
Grand View Research has segmented the Transplant Diagnostic
Market on the basis of technology, product, and geography.
Transplant Diagnostic Market by Technology, 2013 - 2024
(USD Million)
- Molecular
Assays
- PCR-Based
Molecular Assays
- Sequencing-Based
Molecular Assays
- Non-Molecular
Assays
- Serological
Assays
- Mixed
Lymphocyte Culture (MLC) Assays
Transplant Diagnostic Market by Product, 2013 - 2024 (USD
Million)
- Reagents
and Consumables
- Instruments
- Software
and Services
Transplant Diagnostics Market, by Region, 2013- 2024 (USD
Million)
- North
America
- U.S.
Transplant Diagnostics Market by Product Type
- Canada
Transplant Diagnostics Market by Product Type
- U.S.Transplant
Diagnostics Market by Technology Type
- Canada
Transplant Diagnostics Market by Technology
- Europe
- Germany
Transplant Diagnostics Market by Product Type
- France
Transplant Diagnostics Market by Product Type
- Germany
Transplant Diagnostics Market by Technology
- France
Transplant Diagnostics Market by Technology
- Asia
Pacific
- China
Transplant Diagnostics Market by Product Type
- India
Transplant Diagnostics Market by Product Type
- China
Transplant Diagnostics Market by Technology
- India
Transplant Diagnostics Market by Technology
- Latin
America
- Brazil
Transplant Diagnostics Market by Product Type
- Mexico
Transplant Diagnostics Market by Product Type
- Brazil
Transplant Diagnostics Market by Technology
- Mexico
Transplant Diagnostics Marketby Technology
- MEA
- South
Africa Transplant Diagnostics Market by Product Type
- South
Africa Transplant Diagnostics Market by Technology
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment